Harold Smith, founder of the Archimedes Center, highlights a critical gap in early-stage biotech funding where promising scientific ideas lack sufficient resources to prove their merit. This issue impedes healthcare research progress due to insufficient capital and infrastructure support, leading to high failure rates among startups trying to bridge the discovery-to-commercialization gap. Smith advocates for greater investment in foundational research infrastructure to nurture innovative ideas into viable products, emphasizing the need for a cultural shift that values long-term scientific exploration over immediate financial returns.
Read the full article at Digital Journal
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
